Insider selling at Candel is routine and immaterial at 0.04% of market cap. Monitor for any subsequent 8-K or press release that could explain the timing, but this cluster alone does not warrant action. The company has strong analyst support (87% bullish) and recent positive historical stock drift, suggesting this is likely liquidity-driven selling by executives, not a bearish signal.
Price Chart
Executive Summary
Two C-suite insiders at Candid Therapeutics sold a combined ~$306K in open-market transactions on June 29, representing ~0.04% of market cap. While this is a cluster of sales by the CSO and CTO on the same day, the dollar amount is immaterial relative to the $724M market cap, and the trades align with a post-blackout window opening pattern rather than informed selling. The filing also includes routine director grants with no cash value.
Key Financial Metrics
Key Facts
- CSO Francesca Barone sold 23,447 shares at $10.06 for ~$236K on 2026-06-29
- CTO Seshu Tyagarajan sold 7,000 shares at $10.02 for ~$70K on 2026-06-29
- Three directors received non-cash grants totaling ~$34K on 2026-06-30
- Total open-market cash sale is ~$306K, which is ~0.04% of the $724M market cap
- No open-market insider purchases were reported in the cluster
Financial Impact
Two C-suite insiders sold a combined 30,447 shares for ~$306K in open market sales; this is ~0.04% of market cap, well below 0.1% materiality floor.
Risk Factors
- C-suite executives selling on the same day could signal upcoming negative catalysts, though the trivial dollar amount makes this unlikely
- Biotech sector volatility: clinical trial results or regulatory updates could overshadow insider activity
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CADL-1782977699394 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 1, 2026 25d ago | Press Release | $10.16 | awaiting T+60 | — | $7.79 (−23.33%) |
Sep 30, 2026 26d ago | Press Release | $10.44 | awaiting T+60 | — | $7.79 (−25.38%) |
Sep 10, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Sep 9, 2026 6w ago | 8-K | $11.33 | awaiting T+60 | — | $7.79 (−31.24%) |
Aug 15, 2026 10w ago | Institutional Cluster | $12.16 | awaiting T+60 | — | $7.79 (−35.94%) |
Aug 13, 2026 10w ago | 8-K | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 13, 2026 10w ago | Press Release | $11.80 | awaiting T+60 | — | $7.79 (−33.98%) |
Aug 3, 2026 12w ago | Press Release | $10.07 | awaiting T+60 | — | $7.79 (−22.64%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
Jul 1, 2026 16w ago | Insider Cluster | $9.83 $11.19 | ▲ +13.84% | ▲ +11.04% | $7.79 (−20.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers